» Articles » PMID: 34615699

Exploring the 175-year History of Spirometry and the Vital Lessons It Can Teach Us Today

Overview
Journal Eur Respir Rev
Specialty Pulmonary Medicine
Date 2021 Oct 7
PMID 34615699
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

175 years have elapsed since John Hutchinson introduced the world to his version of an apparatus that had been in development for nearly two centuries, the spirometer. Though he was not the first to build a device that sought to measure breathing and quantify the impact of disease and occupation on lung function, Hutchison coined the terms and that are still in use today, securing his place in medical history. As Hutchinson envisioned, spirometry would become crucial to our growing knowledge of respiratory pathophysiology, from Tiffeneau and Pinelli's work on forced expiratory volumes, to Fry and Hyatt's description of the flow-volume curve. In the 20th century, standardization of spirometry further broadened its reach and prognostic potential. Today, spirometry is recognized as essential to respiratory disease diagnosis, management and research. However, controversy exists in some of its applications, uptake in primary care remains sub-optimal and there are concerns related to the way in which race is factored into interpretation. Moving forward, these failings must be addressed, and innovations like Internet-enabled portable spirometers may present novel opportunities. We must also consider the physiologic and practical limitations inherent to spirometry and further investigate complementary technologies such as respiratory oscillometry and other emerging technologies that assess lung function. Through an exploration of the storied history of spirometry, we can better contextualize its current landscape and appreciate the trends that have repeatedly arisen over time. This may help to improve our current use of spirometry and may allow us to anticipate the obstacles confronting emerging pulmonary function technologies.

Citing Articles

The epithelial era of asthma research: knowledge gaps and future direction for patient care.

Brightling C, Marone G, Aegerter H, Chanez P, Heffler E, Pavord I Eur Respir Rev. 2024; 33(174.

PMID: 39694589 PMC: 11653196. DOI: 10.1183/16000617.0221-2024.


ERS/ATS Global Lung Function Initiative normal values and classifying severity based on z-scores instead of per cent predicted.

Ong-Salvador R, Laveneziana P, de Jongh F Breathe (Sheff). 2024; 20(3):230227.

PMID: 39660084 PMC: 11629165. DOI: 10.1183/20734735.0227-2023.


Area under the inspiratory flow-volume curve (AIN): Proposed normative values.

Ioachimescu O, Stoller J PLoS One. 2024; 19(8):e0307966.

PMID: 39088417 PMC: 11293737. DOI: 10.1371/journal.pone.0307966.


Time to re-set our thinking about airways disease: lessons from history, the resurgence of chronic bronchitis / PBB and modern concepts in microbiology.

Everard M, Priftis K, Koumbourlis A, Shields M Front Pediatr. 2024; 12:1391290.

PMID: 38910961 PMC: 11190372. DOI: 10.3389/fped.2024.1391290.


Is lung function in a race against time?.

Cooper B, Stanojevic S Exp Physiol. 2024; 109(8):1244-1245.

PMID: 38699789 PMC: 11291856. DOI: 10.1113/EP091490.


References
1.
Kouri A, Gupta S, Yadollahi A, Ryan C, Gershon A, To T . Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic. Chest. 2020; 158(6):2502-2510. PMC: 7345485. DOI: 10.1016/j.chest.2020.06.065. View

2.
Ioachimescu O, Stoller J . An Alternative Spirometric Measurement. Area under the Expiratory Flow-Volume Curve. Ann Am Thorac Soc. 2020; 17(5):582-588. PMC: 7193817. DOI: 10.1513/AnnalsATS.201908-613OC. View

3.
Karimi-Shah B, Chowdhury B . Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib. N Engl J Med. 2015; 372(13):1189-91. DOI: 10.1056/NEJMp1500526. View

4.
King G, Bates J, Berger K, Calverley P, de Melo P, Dellaca R . Technical standards for respiratory oscillometry. Eur Respir J. 2019; 55(2). DOI: 10.1183/13993003.00753-2019. View

5.
Bang K, Gergen P, Kramer R, Cohen B . The effect of pulmonary impairment on all-cause mortality in a national cohort. Chest. 1993; 103(2):536-40. DOI: 10.1378/chest.103.2.536. View